The Company launched with a small team of five chemists in a laboratory located at Murdoch University.

Fast forward 20 years, we’ve moved and grown into a new, state-of-the-art facility in Technology Park, Bentley, arguably the best equipped private laboratory in the southern hemisphere for small molecule synthesis.

As an accredited ISO 9001:2015, 17025 & 17034 lab facility, Epichem’s core business services include:

Medicinal Chemistry
Custom Synthesis and Technical Services
Reference Materials
Analytical Services

Epichem consists of agile and flexible thinkers that allow us to work within different scientific disciplines to tackle complex projects that are tailored to our client`s needs.

Epichem is a wholly-owned subsidiary of PharmAust Ltd, a public company listed on the Australian Stock Exchange. PharmAust is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development.

Epichem - Model EPL-NP1 - Paclitaxel - Brochure